Transferrin-conjugated liposome targeting of photosensitizer AIPcS4 to rat bladder carcinoma cells

Journal of the National Cancer Institute

Volumn 96, Issue 21, 2004, Pages 1620-1630

  Derycke, Annelies S L ^a   Kamuhabwa, Appolinary ^a   Gijsens, Antoon ^b   Roskams, Tania ^a   De Vos, Dirk ^a   Kasran, Ahmad ^a   Huwyler, Jörg ^c   Missiaen, Ludwig ^a   de Witte, Peter A M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b EMEA   (United Kingdom)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; TETRASULFOPHTHALOCYANINE ALUMINUM; TRANSFERRIN; ANTINEOPLASTIC AGENT; INDOLE DERIVATIVE; MACROGOL DERIVATIVE; ORGANOMETALLIC COMPOUND; PHOTOSENSITIZING AGENT; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CARCINOMA; BLADDER MUSCLE; CARCINOMA CELL; CELL KILLING; CELL LEVEL; CELL VIABILITY; CLONOGENIC ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG EFFICACY; DRUG ISOLATION; DRUG TARGETING; DRUG TISSUE LEVEL; ENCAPSULATION; FEMALE; FLUORESCENCE MICROSCOPY; IN VITRO STUDY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; SUBMUCOSA; TRANSITIONAL CELL CARCINOMA; UROTHELIUM; ANIMAL; BLADDER TUMOR; CANCER TRANSPLANTATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; PHOTOCHEMOTHERAPY;

ADMINISTRATION, INTRAVESICAL; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDOLES; LIPOSOMES; MICROSCOPY, FLUORESCENCE; NEOPLASM TRANSPLANTATION; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POLYETHYLENE GLYCOLS; RATS; RECEPTORS, TRANSFERRIN; TRANSFERRIN; URINARY BLADDER NEOPLASMS;

EID: 7944238712     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh314     Document Type: Article

References (36)

1. Sibata CH, Colussi VC, Oleinick NL, Kinsella TJ. Photodynamic therapy in oncology. Expert Opin Pharmacother 2001;2:917-27.
2. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer 2003;3:380-7.
3. Shakley DC, Whitehurst C, Moore JV, George NJ, Betts CD, Clarke NW. Light penetration in bladder tissues: implications for the intravesical photodynamic therapy of bladder tumors. BJU Int 2000;86:638-43.
4. Jichlinski P, Leisinger HJ. Photodynamic therapy in superficial bladder cancer: past, present and future. Urol Res 2001;29:396-405.
5. Harty JI, Amin M, Wieman TJ, Tseng MT, Ackerman D, Broghamer W. Complications of whole bladder dihematoporphyrin ether photodynamic therapy. J Urol 1989;141:1341-6.
6. Manyak MJ. Photodynamic therapy: principles and urological applications. Semin Urol 1991;9:192-202.
7. Derycke AS, de Witte PA. Transferrin-mediated targeting of hypericin embedded in sterically stabilized PEG liposomes. Int J Oncol 2002;20:181-7.
8. Singh M. Transferrin as a targeting ligand for liposomes and anticancer drugs. Curr Pharm Des 1999;5:443-51.
9. Seymour GJ, Walsh MD, Lavin MF, Strutton G, Gardiner RA. Transferrin receptor expression by human bladder transitional cell carcinomas. Urol Res 1987;15:341-4.
10. Rahman SA, Yokoyama M, Nishio S, Takeuchi M. Flow cytometric evaluation of transferrin receptor in transitional cell carcinoma. Urol Res 1997;25:325-9.
11. Basar I, Ayhan A, Bircan K, Ergen A, Tasar C. Transferrin receptor activity as a marker in transitional cell carcinoma of the bladder. Br J Urol 1991;67:165-8.
12. Smith NW, Strutton GM, Walsh MD, Wright GR, Seymour GJ, Lavin MF, et al. Transferrin receptor expression in primary superficial human bladder tumours identifies patients who develop recurrences. Br J Urol 1990;65:339-44.
13. Becker A, Riefke B, Ebert B, Sukowski U, Rinneberg H, Semmler W, et al. Macromolecular contrast agents for optical imaging of tumors: comparison of indotricarbocyanine-labeled human serum albumin and transferrin. Photochem Photobiol 2000;72:234-41.
14. Ponka P, Beaumont C, Richardson DR. Function and regulation of transferrin and ferritin. Semin Hematol 1998;35:35-54.
15. Moan J, Berg K, Bommer JC, Western A. Action spectra of phthalocyanines with respect to photosensitization of cells. Photochem Photobiol 1992;56:171-5.
16. Allen TM. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol Sci 1994;15:215-20.
17. Wu NZ, Da D, Rudoll TL, Needham D, Whorton AR, Dewhirst MW. Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue. Cancer Res 1993;53:3765-70.
18. Huwyler J, Wu D, Pardridge WM. Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci U S A 1996;93:14164-9.
19. Hansen CB, Kao GY, Moase EH, Zalipsky S, Allen TM. Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimisation of coupling procedures. Biochim Biophys Acta 1995;1239:133-44.
20. Stewart JC. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 1980;104:10-14.
21. Wessel D, Flugge UI. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem 1984;138:141-3.
22. 4 to HeLa cells by transferrin conjugated PEG liposomes. Int J Cancer 2002; 101:78-85.
23. Thatte HS, Bridges KR, Golan DE. Microtubule inhibitors differentially affect translational movement, cell surface expression, and endocytosis of transferrin receptors in K562 cells. J Cell Physiol 1994;160:345-57.
24. Galbraith GM, Galbraith RM. Metabolic and cytoskeletal modulation of transferrin receptor mobility in mitogen-activated human lymphocytes. Clin Exp Immunol 1980;42:285-93.
25. Baynes R, Bukofzer G, Bothwell T, Bezwoda W, Macfarlane B. Transferrin receptors and transferrin iron uptake by cultured human blood monocytes. Eur J Cell Biol 1987;43:372-6.
26. Xiao Z, McCallum TJ, Brown KM, Miller GG, Halls SB, Parney I, et al. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumor model. Br J Cancer 1999;81:638-46.
27. Kamuhabwa A, Cosserat-Gerardin I, Didelon J, Notter D, Guillemin F, Roskams T, et al. Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapy. Int J Cancer 2002;97:253-60.
28. Hurst RE, Zebrowski R. Identification of proteoglycans present at high density on bovine and human bladder luminal surface. J Urol 1994;152:1641-4.
29. Filbeck T, Pichlmeier U, Knuechel R, Wieland WF, Roessler W. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors. J Urol 2002;168:67-71.
30. Kriegmair M, Zaak D, Rothenberger KH, Rassweiler J, Jocham D, Eisenberger F, et al. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. J Urol 2002;168:475-8.
31. Cornish J, Nickel JC, Vanderwee M, Costerton JW. Ultrastructural visualization of human bladder mucous. Urol Res 1990;18:263-6.
32. Blain F, Tkalec AL, Shao Z, Poulin C, Pedneault M, Gu K, et al. Expression system for high levels of GAG lyase gene expression and study of the hepA upstream region in Flavobacterium heparinum. J Bacteriol 2002;184:3242-52.
33. Parsons CL, Greenspan C, Moore SW, Mulholland SG. Role of surface mucin in primary antibacterial defense of bladder. Urology 1977;9:48-52.
34. Rubben H, Friedrichs R, Stuhlsatz H, Cosma S, Lutzeyer W. Quantitative analysis of glycosaminoglycans in urothelium and bladder wall of calf. Urology 1983;22:655-7.
35. Allen TM, Lopes de Menezes DI, Hansen CB, Moase EH. Stealth liposomes for the targeting of drugs in cancer therapy. In: Gregoriadis G, McCormack B, editors. Targeting of drugs 6: strategies for stealth therapeutic systems. New York (NY): Plenum Press; 1998. p. 61-75.
36. Bachor R, Flotte TJ, Scholz M, Dretler S, Hasan T. Comparison of intravenous and intravesical administration of chloro-aluminium sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model. J Urol 1992;147:1404-10.